Imux
New York City, US · 1 known investors
Find your way into Imux
71 people in our graph share verified history with the Imux team — schools, employers, funds. One of them is your warm intro.
Nick Zurickunlockedknows Jason Tardio · together at Saint Joseph's University
×6knows the team · via Saint Joseph's University
×5knows the team · via The College of New Jersey
Immunic is a clinical-stage biopharmaceutical company developing oral small molecule treatments for neurologic and autoimmune diseases with unmet medical needs.
Founders & leadership
DH
Dr. Hella KohlhofCo-Founder, Chief Scientific Officer
EL
Erik LundgreninChief Executive Officer
JT
Jason TardioinPresident and Chief Operating OfficerJason Tardio has held C-level pharmaceutical executive roles across specialty, rare disease, and large-market brands, with experience in general management, product launches, and cross-functional leadership in the United States, Latin America, and global markets.
MA
Michael A. PanzarainChief Medical Officer
Investors · 1
Frequently asked questions
- What does Imux do?
- Immunic is a clinical-stage biopharmaceutical company developing oral small molecule treatments for neurologic and autoimmune diseases with unmet medical needs.
- Who founded Imux?
- Imux was founded by Dr. Hella Kohlhof.
- Who are Imux's investors?
- Imux's investors include Fund+.
- Where is Imux headquartered?
- Imux is headquartered in New York City, US.